These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16344343)

  • 21. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.
    Gilmore CP; Donaldson I; Bö L; Owens T; Lowe J; Evangelou N
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):182-7. PubMed ID: 18829630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartoacylase gene knockout results in severe vacuolation in the white matter and gray matter of the spinal cord in the mouse.
    Surendran S; Campbell GA; Tyring SK; Matalon R
    Neurobiol Dis; 2005 Mar; 18(2):385-9. PubMed ID: 15686967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal cord axonal loss in multiple sclerosis: a post-mortem study.
    Ganter P; Prince C; Esiri MM
    Neuropathol Appl Neurobiol; 1999 Dec; 25(6):459-67. PubMed ID: 10632896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.
    McGavern DB; Murray PD; Rivera-Quiñones C; Schmelzer JD; Low PA; Rodriguez M
    Brain; 2000 Mar; 123 Pt 3(Pt 3):519-31. PubMed ID: 10686175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
    Evangelou N; DeLuca GC; Owens T; Esiri MM
    Brain; 2005 Jan; 128(Pt 1):29-34. PubMed ID: 15548559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy.
    Jaros E; Mahad DJ; Hudson G; Birchall D; Sawcer SJ; Griffiths PG; Sunter J; Compston DA; Perry RH; Chinnery PF
    Neurology; 2007 Jul; 69(2):214-6. PubMed ID: 17620555
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E; Petsas N; Tona F; Prosperini L; Raz E; Pace G; Pozzilli C; Pantano P
    PLoS One; 2013; 8(5):e63250. PubMed ID: 23696802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.
    Papinutto N; Schlaeger R; Panara V; Caverzasi E; Ahn S; Johnson KJ; Zhu AH; Stern WA; Laub G; Hauser SL; Henry RG
    J Magn Reson Imaging; 2015 Sep; 42(3):698-708. PubMed ID: 25483607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
    Fisher E; Nakamura K; Lee JC; You X; Sperling B; Rudick RA
    Mult Scler; 2016 Apr; 22(5):668-76. PubMed ID: 26238463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible cervical hydromyelia in subacute combined degeneration.
    Canas N; Calado S; Ribeiro C; Vale J
    Neurology; 2005 Aug; 65(3):E7. PubMed ID: 16087892
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.
    Ceccarelli A; Rocca MA; Valsasina P; Rodegher M; Pagani E; Falini A; Comi G; Filippi M
    Hum Brain Mapp; 2009 Sep; 30(9):3009-19. PubMed ID: 19172642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging.
    Raz E; Cercignani M; Sbardella E; Totaro P; Pozzilli C; Bozzali M; Pantano P
    Radiology; 2010 Nov; 257(2):448-54. PubMed ID: 20858849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.